Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited)

v3.22.2
Condensed Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited) - USD ($)
Series B Preferred Stock [Member]
Preferred Stock [Member]
Series E-1 Preferred Stock [Member]
Preferred Stock [Member]
Common Stock [Member]
Deferred Stock Based Compensation [Member]
Additional Paid-in Capital [Member]
Stock Subscription [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Dec. 31, 2020 $ 49 $ (148,333) $ 11,023,738 $ (25,000) $ (15,911,895) $ (5,061,441)
Beginning balance, shares at Dec. 31, 2020 281 7,650 486,806          
Common stock issued for services, including a director $ 1 115,000 537,391 652,392
Common stock issued for services, including a director, shares     6,250          
Conversion of debentures and accrued expenses $ 2 515,066 515,068
Conversion of debentures and accrued expenses, shares     15,825          
Conversion of bridge notes and accrued interest to common stock $ 17 4,378,471 4,378,488
Conversion of bridge notes and accrued interest to common stock, shares     165,692          
Conversion of Series A preferred stock to common stock $ 2 662,498 (542,500) 120,000
Conversion of Series A preferred stock to common stock, shares     18,750          
Series A, preferred stock contractual dividends (7,899) (7,899)
Issuance of Series B, preferred stock for cash $ 2 2,195,998 25,000 2,221,000
Issuance of Series B, preferred stock for cash, shares 2,196              
Issuance of Series B, conversion of notes payable to preferred stock 23,000 23,000
Issuance of Series B, conversion of notes payable to preferred stock, shares 23              
Stock-based compensation to employees and directors $ 1 (4,141,777) 6,527,999 2,386,223
Stock-based compensation to employees and directors, shares   850            
Net loss period   (4,406,059) (4,406,059)
Ending balance, value at Mar. 31, 2021 $ 2 $ 1 $ 71 (4,175,110) 25,856,262 (20,860,454) 820,772
Ending balance, shares at Mar. 31, 2021 2,500 8,500 693,323          
Beginning balance, value at Dec. 31, 2020 $ 49 (148,333) 11,023,738 (25,000) (15,911,895) $ (5,061,441)
Beginning balance, shares at Dec. 31, 2020 281 7,650 486,806          
Conversion of debentures and accrued expenses, shares               15,825
Conversion of bridge notes and accrued interest to common stock, shares               165,692
Stock-based compensation to employees and directors, shares               6,250
Net loss period               $ (7,310,262)
Ending balance, value at Jun. 30, 2021 $ 2 $ 1 $ 71 (1,702,528) 26,012,562 (23,920,294) 389,813
Ending balance, shares at Jun. 30, 2021 2,500 8,500 693,323          
Beginning balance, value at Mar. 31, 2021 $ 2 $ 1 $ 71 (4,175,110) 25,856,262 (20,860,454) 820,772
Beginning balance, shares at Mar. 31, 2021 2,500 8,500 693,323          
Series A, preferred stock contractual dividends (7,180) (7,180)
Stock-based compensation to employees and directors 2,439,249 2,439,249
Net loss period (2,904,203) (2,904,203)
Stock-based compensation for services and warrant modification 33,333 7,841 41,174
Deemed dividend from warrant modification 155,639 (155,639)
Ending balance, value at Jun. 30, 2021 $ 2 $ 1 $ 71 (1,702,528) 26,012,562 (23,920,294) 389,813
Ending balance, shares at Jun. 30, 2021 2,500 8,500 693,323          
Beginning balance, value at Dec. 31, 2021 $ 2 $ 165 (900,742) 29,765,585 (29,281,674) (416,664)
Beginning balance, shares at Dec. 31, 2021 1,509 1,652,102          
Common stock issued for services, including a director $ 3 254,748 254,751
Common stock issued for services, including a director, shares     28,750          
Conversion of debentures and accrued expenses $ 1 34,999 35,000
Conversion of debentures and accrued expenses, shares     5,469          
Series A, preferred stock contractual dividends (7,202) (7,202)
Net loss period (1,788,246) (1,788,246)
Incremental value from warrant modifications 41,225 (41,225)
40:1 Reverse Split Fractional Shares Adjustment
40:1 Reverse Split Fractional Shares Adjustment, shares     266          
Series B, preferred stock contractual dividends (37,206) (37,206)
Accretion of stock-based compensation to employees and directors 213,041 107,312 320,353
Ending balance, value at Mar. 31, 2022 $ 2 $ 169 (687,701) 30,159,461 (31,111,145) (1,639,214)
Ending balance, shares at Mar. 31, 2022 1,509 1,686,587          
Beginning balance, value at Dec. 31, 2021 $ 2 $ 165 (900,742) 29,765,585 (29,281,674) $ (416,664)
Beginning balance, shares at Dec. 31, 2021 1,509 1,652,102          
Common stock issued for services, including a director, shares               18,750
Conversion of debentures and accrued expenses, shares               5,469
Stock-based compensation to employees and directors, shares               18,750
Net loss period               $ (3,071,692)
Ending balance, value at Jun. 30, 2022 $ 2 $ 169 (472,292) 30,327,583 (32,394,591) (2,539,129)
Ending balance, shares at Jun. 30, 2022 1,509 1,686,587          
Beginning balance, value at Mar. 31, 2022 $ 2 $ 169 (687,701) 30,159,461 (31,111,145) (1,639,214)
Beginning balance, shares at Mar. 31, 2022 1,509 1,686,587          
Series A, preferred stock contractual dividends (6,018) (6,018)
Net loss period (1,283,446) (1,283,446)
Series B, preferred stock contractual dividends (38,035) (38,035)
Accretion of stock-based compensation to employees and directors 215,409 212,175 427,584
Ending balance, value at Jun. 30, 2022 $ 2 $ 169 $ (472,292) $ 30,327,583 $ (32,394,591) $ (2,539,129)
Ending balance, shares at Jun. 30, 2022 1,509 1,686,587